Basal Cell Nevus Syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Basal Cell Nevus Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
"PTCH"-ing it together: a basal cell nevus syndrome review.
|
23725561 |
2013 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
.The relationship of mutations in the patched gene PTCH and nevoid basal cell carcinoma (NBCC) or Gorlin syndrome is well established.
|
21651513 |
2012 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Gorlin syndrome: identification of 4 novel germ-line mutations of the human patched (PTCH) gene. Mutations in brief no. 137. Online.
|
10200051 |
1998 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Basal cell nevus syndrome (BCNS; also nevoid basal cell carcinoma syndrome [NBCCS]; Gorlin's syndrome) is an autosomal dominant syndrome characterized by multiple basal cell carcinomas, keratocysts, and developmental skeletal defects.
|
11277394 |
2001 |
Basal Cell Nevus Syndrome
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Basal cell nevus syndrome (Gorlin syndrome) is an autosomal dominant disorder characterized by the presence of multiple basal cell carcinomas (BCC), odontogenic keratocysts, palmoplantar pits, and calcification in the falx cerebri caused by mutational inactivation of the PTCH gene.
|
15690381 |
2005 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
BCNS linked to chromosome 9q22 (D9S1120) just proximal to the PTCH1 gene (NPL=3.26, P=0.003; parametric two-point LOD=2.4, parametric multipoint LOD=3.7).
|
16733713 |
2006 |
Basal Cell Nevus Syndrome
|
1.000 |
GermlineCausalMutation
|
disease |
ORPHANET |
NBCCS is caused by mutations in the PTCH1 gene and is transmitted as an autosomal dominant trait with complete penetrance and variable expressivity.
|
19032739 |
2008 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Nevoid basal cell carcinoma syndrome with cleft lip and palate associated with the novel PTCH gene mutations.
|
19521425 |
2009 |
Basal Cell Nevus Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Basal cell nevus syndrome (BCNS or Gorlin syndrome, OMIM: 109400) is a rare autosomal dominant disorder with high penetrance.
|
19557015 |
2009 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Basal cell nevus syndrome (BCNS), also known as Gorlin syndrome (OMIM #109400) is a well-described rare autosomal dominant condition due to haploinsufficiency of PTCH1.
|
22190277 |
2012 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Gorlin syndrome (GS) is an autosomal dominant disorder that predisposes affected individuals to developmental defects and tumorigenesis, and caused mainly by heterozygous germline PTCH1 mutations.
|
26544948 |
2015 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by developmental defects and tumorigenesis such as medulloblastomas and basal cell carcinomas, caused by mutations of the patched-1 (PTCH1) gene.
|
27561271 |
2017 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Basal cell naevus syndrome (BCNS) is an autosomal dominant disorder most commonly caused by a germline mutation in the Drosophila homologue of patched-1 gene (PTCH1).
|
27658957 |
2017 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder mainly caused by heterozygous mutations of PTCH1.
|
28342698 |
2017 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Gorlin syndrome is associated with germline mutations in components of the Sonic Hedgehog pathway, including Patched1 (<i>PTCH1)</i> and Suppressor of fused (<i>SUFU)</i><i>SUFU</i> mutation carriers appear to have an especially high risk of early-onset medulloblastoma.
|
28620006 |
2017 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Basal cell nevus syndrome (BCNS), or Gorlin syndrome, is a rare, autosomal-dominant inherited genodermatosis linked to a mutation in the PTCH<sub>1</sub> (patched 1) gene and is characterized by a broad range of anomalies.
|
28686751 |
2017 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
BCNS most commonly is caused by a germline mutation in the patched-1 (PTCH1) gene.
|
29575684 |
2018 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
BCNS is mainly caused by mutations in PTCH1, an onco-suppressor gene that maps at 9q22.3 region.
|
31578813 |
2020 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTCH gene deletion was detected in the tumors of both patients with NBCCS.
|
10375116 |
1999 |
Basal Cell Nevus Syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Ptch1-deficient (Ptch1+/-) mice and patients with nevoid basal cell carcinoma syndrome showed high bone mass in adults.
|
18477452 |
2008 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTCH gene mutations are reported in patients with Gorlin syndrome and sporadic cutaneous BCCs.
|
19278434 |
2009 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTCH mutation can be found in sporadically or NBCCS associated KOCTs.
|
21507611 |
2011 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Patched 1 gene mutation has also been identified as the underlying mechanism in most cases of Gorlin syndrome (also known as basal cell nevus syndrome or nevoid basal cell carcinoma syndrome).
|
22177103 |
2011 |
Basal Cell Nevus Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
PTCH1 mutation can be found both in sporadic or NBCCS associated KCOTs.
|
22952776 |
2012 |